• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-Xa assay monitoring for thromboprophylaxis in critical care patients with Covid-19 pneumonia.

作者信息

Quarterman Clare, Cole Oana

机构信息

Liverpool Heart and Chest NHS Foundation Trust, Liverpool, UK.

出版信息

J Intensive Care Soc. 2023 Nov;24(3 Suppl):37-38. doi: 10.1177/1751143720966279. Epub 2020 Oct 20.

DOI:10.1177/1751143720966279
PMID:37928075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10621526/
Abstract
摘要

相似文献

1
Anti-Xa assay monitoring for thromboprophylaxis in critical care patients with Covid-19 pneumonia.新冠病毒肺炎危重症患者血栓预防的抗Xa因子检测监测
J Intensive Care Soc. 2023 Nov;24(3 Suppl):37-38. doi: 10.1177/1751143720966279. Epub 2020 Oct 20.
2
Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit.重症监护病房中感染 SARS-CoV2 的患者的肝素剂量、水平和耐药性。
Int J Lab Hematol. 2021 Dec;43(6):1284-1290. doi: 10.1111/ijlh.13543. Epub 2021 Apr 14.
3
Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019.抗 Xa 定向抗栓预防 2019 年冠状病毒病危重症患者血栓形成。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221116350. doi: 10.1177/10760296221116350.
4
The Effectiveness of the Intermediate and Therapeutic Doses of Enoxaparin in COVID-19 Patients: A Comparative Study of Factor Xa Inhibition.依诺肝素中、治疗剂量在 COVID-19 患者中的疗效：Xa 因子抑制的对比研究。
Acta Haematol. 2023;146(2):137-143. doi: 10.1159/000528736. Epub 2022 Dec 20.
5
Effects of dalteparin on anti-Xa activities cannot be predicted in critically ill COVID-19 patients.在危重症 COVID-19 患者中，无法预测达肝素对抗 Xa 活性的影响。
Br J Clin Pharmacol. 2022 Jun;88(6):2982-2987. doi: 10.1111/bcp.15208. Epub 2022 Jan 17.
6
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19.标准剂量与中等剂量依诺肝素用于新型冠状病毒肺炎重症患者抗Xa因子指导的血栓预防
Thromb J. 2021 Nov 15;19(1):87. doi: 10.1186/s12959-021-00337-z.
7
Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study.调整住院肥胖患者的血栓预防价值：依诺肝素两种方案的对比研究：ITOHENOX 研究。
Thromb Res. 2017 Jul;155:1-5. doi: 10.1016/j.thromres.2017.04.011. Epub 2017 Apr 12.
8
Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID-19 intensive care unit patients.COVID-19 重症监护病房患者中那屈肝素预防血栓的群体药代动力学。
Br J Clin Pharmacol. 2023 May;89(5):1617-1628. doi: 10.1111/bcp.15634. Epub 2022 Dec 26.
9
Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.达肝素对合并肾功能不全的重症内科及外科患者的血栓预防作用
J Crit Care. 2005 Dec;20(4):357-63. doi: 10.1016/j.jcrc.2005.09.009.
10
Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study.接受依诺肝素进行血栓预防的重症患者中，抗Xa因子活性与静脉血栓栓塞无关：一项回顾性观察研究。
Front Med (Lausanne). 2022 Apr 29;9:888451. doi: 10.3389/fmed.2022.888451. eCollection 2022.

引用本文的文献

1
Thromboprophylaxis in COVID-19 - Rationale and considerations.COVID-19 相关的血栓预防——基本原理和注意事项。
Adv Biol Regul. 2021 Aug;81:100819. doi: 10.1016/j.jbior.2021.100819. Epub 2021 Jul 23.

本文引用的文献

1
Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels.新型冠状病毒肺炎患者急性肺栓塞的CT血管造影表现及其与D-二聚体水平的关系
Radiology. 2020 Sep;296(3):E189-E191. doi: 10.1148/radiol.2020201561. Epub 2020 Apr 23.
2
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.新型冠状病毒病 2019 感染相关静脉血栓栓塞症的预防与治疗：指南出台前的共识声明。
Thromb Haemost. 2020 Jun;120(6):937-948. doi: 10.1055/s-0040-1710019. Epub 2020 Apr 21.
3
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
4
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis.D-二聚体与2019冠状病毒病的严重程度相关：一项汇总分析。
Thromb Haemost. 2020 May;120(5):876-878. doi: 10.1055/s-0040-1709650. Epub 2020 Apr 3.
5
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.